Racial Disparities and Diagnosis-to-Treatment Time Among Patients Diagnosed with Breast Cancer in South Carolina
Oluwole Adeyemi Babatunde, Jan M. Eberth, Tisha M. Felder, Robert Moran, Chanita Hughes-Halbert, Samantha Truman, James R. Hebert, Sue Heiney and Swann Arp Adams
Journal of racial and ethnic health disparities, v 9(1), pp 124-134
Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology
Objectives Diagnosis-to-treatment interval is an important quality measure that is recognized by the National Accreditation Program for Breast Centers, and the American Society of Breast Surgeons and the National Quality Measures for Breast Care. The aim of this study was to assess factors related to delays in receiving breast cancer treatment.
Methods This retrospective cohort study (2002 to 2010) used data from the South Carolina Central Cancer Registry (SCCCR) and Office of Revenue and Fiscal Affairs (RFA) to examine racial differences in diagnosis-to-treatment time (in days), with adjuvant hormone receipt, surgery, chemotherapy, and radiotherapy assessed separately. Chi-square tests, and logistic regression and generalized linear models were used to compare diagnosis-to-treatment days.
Results Black women on average received adjuvant hormone therapy, surgery, chemotherapy, and radiotherapy 25, 8, 7, and 3 days later than their White counterparts, respectively. Black women with local stage cancer had later time to surgery (OR: 1.6; CI: 1.2-2.2) compared with White women with local stage cancer. Black women living in rural areas had higher odds (OR: 2.0; CI: 1.1-3.7) of receiving late chemotherapy compared with White women living in rural areas. Unmarried Black women also had greater risk (OR: 2.0; CI: 1.0-4.0) of receiving late radiotherapy compared to married White women.
Conclusions To improve timely receipt of effective BrCA treatments, programs aimed at reducing racial disparities may need to target subgroups of Black breast cancer patients based on their social determinants of health and geographic residence.
Racial Disparities and Diagnosis-to-Treatment Time Among Patients Diagnosed with Breast Cancer in South Carolina
Creators
Oluwole Adeyemi Babatunde - University of South Carolina
Jan M. Eberth - University of South Carolina
Tisha M. Felder - University of South Carolina
Robert Moran - University of South Carolina
Chanita Hughes-Halbert - University of South Carolina
Samantha Truman - University of South Carolina
James R. Hebert - Connecting Health Innovations
Sue Heiney - University of South Carolina
Swann Arp Adams - University of South Carolina
Publication Details
Journal of racial and ethnic health disparities, v 9(1), pp 124-134
Publisher
SPRINGER INT PUBL AG
Number of pages
11
Grant note
R21 CA 235852 / National Cancer Institute's R21 grant
GTDR17500160 / Interdisciplinary Graduate Training Program in Cancer Disparities (IGniTE-CD) program - Susan G. Komen
R15CA179355 / National Cancer Institute's R15 grant
F99 CA 222722; K00 CA 222722 / National Cancer Institute's K00 Fellowship grant
K01CA193667 / National Cancer Institute Mentored Research Scientist Development Award
Resource Type
Journal article
Language
English
Academic Unit
Health Management and Policy
Web of Science ID
WOS:000607012100002
Scopus ID
2-s2.0-85099306864
Other Identifier
991021855274104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Public, Environmental & Occupational Health
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services